Recent Advances in the Development of Hybrid Molecules/Designed Multiple Compounds with Antiamnesic Properties

Author(s): Michael Decker

Journal Name: Mini-Reviews in Medicinal Chemistry

Volume 7 , Issue 3 , 2007

Become EABM
Become Reviewer
Call for Editor


Novel compounds have been developed that (in many cases) inhibit cholinesterases and concomitantly interact with at least one further pharmacological target, such as 5-HT3 or H3 receptors. But also enzymes like monoamine oxidase and the serotonin transporter have been targeted. Hybrid molecules can also incorporate antioxidant or neuronal Ca2+- channel-blocking structures.

Keywords: Hybrid molecules, Multiple ligands, AChE inhibitors, Serotonin transporter (SERT), monoamine oxidase (MAO), lipoic acid, 5-HT3 receptor, Ca2+-channel blockers

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2007
Page: [221 - 229]
Pages: 9
DOI: 10.2174/138955707780059817
Price: $65

Article Metrics

PDF: 6